Navigation Links
Cosmetic surgery procedures to exceed 55 million in 2015, ASPS study predicts
Date:6/24/2008

omic and non-economic variables to predict cosmetic surgery procedure volume. Finally, they used growth rate analyses to construct models with which to predict the future growth of cosmetic surgery.

The study found the next decade of growth in cosmetic surgery will continue to be driven by the growth of non-surgical procedures. Between 1992 and 2005, the compound annual growth rate was 7.5 percent for surgical procedures and 27.9 for non-surgical procedures, the study noted. In 2005, 34 percent of procedures performed by ASPS Member Surgeons were surgical procedures and 66 percent were non-surgical. In 2005, for non-ASPS members 9.5 percent of their procedures were surgical, while 90.5 percent were non-surgical.

For ASPS members, 12 percent of the procedures they perform will be surgical and 88 percent will be non-surgical in 2015. For non ASPS physicians surgical procedures will make up only 3 percent of their total procedures, while 97 percent will be non-surgical in 2015, the study forecasts.


'/>"/>

Contact: ASPS Media Relations
media@plasticsurgery.org
847-228-9900
American Society of Plastic Surgeons
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Cosmetic Innovators of The Year Announced
2. Cosmetic Procedures Still Booming Despite Economy Concerns
3. International Esthetics, Cosmetics & Spa Conference - Las Vegas
4. Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies
5. New Survey Suggests That Consumers Are Naive to the Risk of Botox Parties and the Importance of FDA Approval for Cosmetic Injectables
6. Cosmetic Skin Fillers May Cause Delayed Side Effects
7. Petition Seeking a Cancer Warning on Cosmetic Talc Powder Products
8. Personal Care Products Council CEO & President Pamela G. Bailey Testifies on FDA Cosmetic Regulation Before U.S. House Committee on Energy and Commerce
9. A Range of Cosmetic Medicine Procedures For Any Age
10. Small is beautiful: A European view of nanotech cosmetics and safety
11. Beauty for Life: The Future of Cosmetic Medicine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...l Nutrition announced today the acquisition of App...ed subsidiary of Natural Nutrition. Natural Nutri... the company will focus its efforts on the busines...oping mobile application market places throughout ...sed on multi platform apps designed to run on devi...
(Date:11/9/2009)...-Asia/ -- Simcere Pharmaceutical Group,(NYSE: SCR...eutical company,specializing in the development, m... proprietary pharmaceuticals in China, today annou...ense in China of Rosuvastatin from Tianjin,Tianda ...on of the,manufacturing license will be effected t...
(Date:11/9/2009)...eer development of scientists and science trainees...inical medicine, AAAS, Science Careers, and Scienc...e called CTSciNet, the Clinical and Translational ...B) November 6, 2009 -- Launched October 20 by Scie... CTSciNet is an online community for people purs...
(Date:11/9/2009)... now available in New York City by pain management...Y (PRWEB) November 9, 2009 -- Davis Bregman , a p...ouse calls to residents of Manhattan in New York C...l by calling the office at 212-918-1629 or sendin...e of being able to see the doctor in the less stre...
(Date:11/9/2009)...form Bill, The Affordable Health Care for American...aturday Night, and Is Expected to Be Signed into L...ith Absolute Confidence. ERISAclaim.com Announced ...cifically for the Compliance with the New Federal ... Hanover Park, IL (PRWEB) November 9, ...
Breaking Medicine News(10 mins):Health News:Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin 2Health News:Social Network for Translational Scientists Launched 2Health News:Social Network for Translational Scientists Launched 3Health News:Social Network for Translational Scientists Launched 4Health News:Davis Bregman MD Now Offering House Calls in Manhattan 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 2Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 3Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 4Health News:The New Healthcare Reform Bill Passed by The Congress Prompted The New Claim Specialist Certification Class from ERISAclaim.com 5
...lecular Corporation, a,pioneer in the development ...lysis systems, announced today that Fran Tuttle ha.... Tuttle is president and chief executive,officer ...ard," said Xceed,s President and,CEO, David Deems....
...as released,today by the U.S. Department of Justic...m Ronald Tenpas, acting Assistant Attorney,General...n here at the,Department of Justice. Joining me to...nmental enforcement,settlement in the history of o...
...use study shows , TUESDAY, Oct. 9 (HealthDay News)...that may lead to a treatment for the hereditary, p...on,s disease (HD). , In mice, a molecule called C2... Disorders (MIND), Boston. Their study appears in ...
...finds , , TUESDAY, Oct. 9 (HealthDay News)...dren who,ve lost weight keep it off, new research ... effect of the maintenance programs wears off over...tudy. Clearly, maintenance treatment was better th...
...ose in commercial managed-care plans, study says ,...icaid enrollees receive lower quality health care ...tients in commercial health plans, a new study fou...nts. , "The policy message is that to the extent t...
...eveloped a potentially novel way to fight colorect...arrages of radiation inside cancer cells, unlike c...s and attack from the outside and cause unwanted s... cells, and whats left over is likely to be easily...
Other Medicine News:Health News:Xceed Molecular Names Fran Tuttle to Its Board of Trustees 2Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 2Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 3Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 4Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 5Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 6Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 7Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 8Health News:Transcript of Press Conference Announcing Settlement in United States Et Al vs. American Electric Power 9Health News:Molecule Promising Against Huntington's Disease 2Health News:Maintenance Treatment Helps Kids Keep Weight Off 2Health News:Maintenance Treatment Helps Kids Keep Weight Off 3Health News:Maintenance Treatment Helps Kids Keep Weight Off 4Health News:Medicaid Managed Care Seems to Fall Short 2Health News:Medicaid Managed Care Seems to Fall Short 3Health News:Medicaid Managed Care Seems to Fall Short 4Health News:Inside job: new radioactive agents for colon cancer work inside cells 2
(Date:11/6/2009)..., Nov. 6 NuVasive, Inc. ... on developing products for minimally disruptive s...the appointment of Michael J. Lambert as Executive...tive November 9, 2009. The Company also announced...,, "Michael will be an excellent complement to ...
(Date:11/6/2009)... Manitoba, Nov. 6 With his propose...has set his sights on cutting name-brand prescript... who fall into the "Part D" coverage gap, universa... about the potential cost-cutting and feel it,s a ... the most powerful lobbyists want a revised progra...
(Date:11/6/2009)...Nov. 6 Cyberonics, Inc. ...will report financial results for the second quart...g April 30, 2010 on Wednesday, November 18, 2009 a...nce call to discuss those results on Thursday, Nov... 2010 Second Quarter Results Conference Call Instr...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 1Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 3Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 4Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 5Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 6Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 7Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 8Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 9Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 10Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 11Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 12Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 13Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 14Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 15Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 16Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 17Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 18Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 19Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 20Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 21Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 22Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 23Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 24Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 25Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 26Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 27Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 28Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 29Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 30Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 31DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 1Nfocus Neuromedical Announces US Clearance of Unique Guiding Catheter with Uni body Internal Skeleton 54719 2
...tors to Better Target Patients for ALIMTA(R), (pem...ll Cell Lung Cancer, BARCELONA, Spain, Sept. 25 ...mall cell lung cancer (NSCLC) that,are classified ...ically,significant higher survival when treated in...d for injection) when compared to,histologically-s...
... (DSMB) Authorizes Enrollment of Cervical ...el, HOPKINTON, Mass., Sept. 24 Alseres,Pharmaceu...ndependent Data,Safety Monitoring Board (DSMB) has...ase I/IIa clinical trial in acute spinal cord inju... treated with a 9 mg dose of,Cethrin(R). This reco...
Other Medicine Technology:Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 2Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 3Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 4Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 5Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 6Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 7Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes 8Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 2Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 3Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 4Alseres Pharmaceuticals' Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial 5
...ed ratchet design provides fingertip ratchet disen... ,The Series I Instrument program offers state-of-...profile, while maintaining strength and durability...gy in tight joint spaces. Series I instruments are...
Graspers Alligator
Scissors Punches
Basket Punches Scoop
Medicine Products: